Lung Radiofrequency Ablation

Sapna K. Jain; Caroline J. Simon; Damian E. Dupuy

doi:10.1055/s-2004-828942

Seminars in Interventional Radiology, Table of Contents

Semin intervent Radiol 2003; 20(4): 307-322
DOI: 10.1055/s-2004-828942

Lung Radiofrequency Ablation

Sapna K. Jain, Caroline J. Simon, Damian E. Dupuy

Rhode Island Hospital, and Brown Medical School, Providence, Rhode Island

Abstract

ABSTRACT

Lung cancer is the leading cause of death among men and women in the United States. Utilizing the best current therapies results in an overall 5-year relative survival rate of 15% for all stages, necessitating the use of alternative therapies. Radiofrequency ablation (RFA) is an expanding modality for the local control of non-small cell lung cancer (NSCLC). The technique and application of RFA in pulmonary neoplasms will be discussed in addition to early clinical experience.

KEYWORDS

Radiofrequency ablation - pulmonary - non-small cell lung cancer

Full Text

References

REFERENCES

1 Parkin D M, Sasco A J. Lung cancer: worldwide variation in occurrence and proportion attributable to tobacco use. Lung Cancer . 1993; 9 1-16
2 American Cancer Society. Cancer Facts & Figures 2003. Atlanta, GA: American Cancer Society; 2003
3 Mountain C F. Revisions in the international system for staging lung cancer. Chest . 1997; 111 1710-1717
4 Van Rens M, de la Riviere A B, Elbers H RJ. et al . Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA. Chest . 2000; 117 374-379
5 Murai N, Koga K, Nagamachi S. et al . Radiotherapy in bone metastses, with special reference to its effect on relieving pain. Gan No Rinsho . 1989; 35 1149-1152
6 Highland A M, Mack P, Breen D J. Radiofrequency thermal ablation of a metastatic lung nodule. Eur Radiol . 2002; l4(suppl) S166-S170
7 Rajdev L, Keller S M. Neoadjuvant and adjuvant therapy of non-small cell lung cancer. Surg Oncol . 2002; 11 243-253
8 Rudd R. Chemotherapy in the treatment of non-small cell lung cancer. Respiratory Disease in Practice . 1991; 7 12-14
9 Macbeth F, Toy E, Coles B. et al .Palliative radiotherapy regimens for non-small cell lung cancer (Cochrane Review). In: The Cochrane Library, Issue 3, 2003 Oxford: Update software:www.update-software.com/cochrane/userGuide.pdf
10 D'Amico T. Local control without resection. J Thorac Cardiovasc Surg . 2003; 125 787-788
11 Ginsberg R J, Rubinstein L V. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg . 1995; 60 615-623
12 Morrison R, Deeley T J, Cleland W P. The treatment of carcinoma of the bronchus: a clinical trial to compare surgery and supervoltage radiotherapy. Lancet . 1963; i 683-684
13 Rowell N P, Williams C J. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable) (Cochrane Review). In: The Cochrane Library, Issue 3, 2003 Oxford: update software:www.update-software.com/cochrane/userGuide.pdf
14 Non-small Cell Lung Cancer Collaborative Group. Chemotherapy for non-small cell lung cancer (Cochrane Review). In: The Cochrane Library, Issue 3, 2003 Oxford: Update software:www.update-software.com/cochrane/userGuide.pdf
15 Dupuy D E, Zagoria R J, Akerley W. et al . Percutaneous radiofrequency ablation of malignancies in the lung. AJR . 2000; 174 57-59
16 Goldberg S N, Dupuy D E. Image-guided radiofrequency tumor ablation: challenges and opportunities - part I. J Vasc Interv Radiol . 2001; 12 1021-1032
17 Dupuy D E, Goldberg S N. Image-guided radiofrequency tumor ablation: challenges and opportunities - part II. J Vasc Interv Radiol . 2001; 12 1135-1148
18 Rose S C, Fotoohi M, Levin D L. et al . Cerebral microembolization during radiofrequency ablation of lung malignancies. J Vasc Interv Radiol . 2002; 13(10) 1051-1054
19 Kvale R A, Simoff M, Prakash U BS. Palliative care. Chest . 2003; 123 284S-311S
20 Griffin J P, Nelson J E, Koch K A. et al . End-of-life care in patients with lung cancer. Chest . 2003; 123 312S-331S
21 SUPPORT principal investigators. A controlled trial to improve care for seriously ill hospitalized patients. JAMA . 1995; 274 1591-1598
22 Watson P N, Evans R J. Intractable pain with lung cancer. Pain . 1987; 29 163-173
23 Langendijk J A, Ten Velde P M G, Aaronson N K. et al . Quality of life after palliative radiotherapy in non-small cell lung cancer: a prospective study. Int J Radiat Oncol Biol Phys . 2000; 47 149-155
24 Dupuy D E, Mayo-Smith W W, Abbott G F, DiPetrillo T. Clinical Applications of Radio-frequency Tumor Ablation in the Thorax. Radiographics . 2002; 22 S259-S269
25 Jain S K, Dupuy D E, Cardarelli G A, Zheng Z, DiPetrillo T A. Percutaneous radiofrequency ablation of pulmonary malignancies:combined treatment with brachytherapy. AJR . 2003; 181 711-715
26 Warzelhan J, Stoelben E, Imdahl A. et al . Results in surgery for primary and metastatic chest wall tumors. Eur J Cardiothorac Surg . 2001; 19 584-588
27 Patti J, Neeman Z, Wood B. Radiofrequency ablation for cancer-associated pain. J Pain . 2002; 3 471-473
28 McCaughan B. Recent advances in managing non-small-cell lung cancer:2. Med J Aust . 1997; 166(suppl) S7-S10
29 Dupuy D E, Safran H, Mayo-Smith W W, Goldberg S N. Radiofrequency ablation of painful osseous metastatic disease: Scientific paper presented at the RSNA annual meeting, Chicago, IL. Radiology . 1998; 209(suppl) 171S-172S
30 Kapural L, Mekhail N. Radiofrequency ablation for chronic pain control. Curr Pain Headache Rep . 2001; 5 517-525
31 Langendijk H, de Jong J, Tywa M. et al . External irradiation versus external irradiation plus endobronchial brachytherapy in inoperable non-small cell lung cancer: a prospective randomized study. Radiother Oncol . 2001; 58 257-268
32 Kishi K, Nakamura H, Sudo A. et al . Tumor debulking by radiofrequency ablation in hypertrophic pulmonary osteoarthropathy associated with pulmonary carcinoma. Lung Cancer . 2002; 38 317-320
33 Ohhigashi S, Nishio T, Watanabe F. et al . Experience with radiofrequency ablation in the treatment of pelvic recurrence in rectal cancer: report of two cases. Dis Colon Rectum . 2001; 44 741-745
34 Callstrom M R, Charboneau J W, Goetz M P. et al . Painful metastases involving bone: feasability of percutaneous CT- and US-guided radio-frequency ablation. Radiology . 2002; 224 87-97
35 Temple L K, Brennan M F. The role of pulmonary metastasectomy in soft tissue sarcoma. Semin Thorac Cardiovasc Surg . 2002; 14 35-44
36 van der Poel G H, Roukema J A, Horenblas S, van Geel N A, Debruyne F M. Metastasectomy in renal cell carcinoma: a multicenter retrospective analysis. Eur Urol . 1999; 35 197-203
37 Piltz S, Meimarakis G, Wichmann M W. et al . Long-term results after pulmonary resection of renal cell carcinoma metastases. Ann Thorac Surg . 2002; 73 1082-1087
38 Okumura S, Kondo H, Tsuboi M. et al . Pulmonary resection for metastatic colorectal cancer: experience with 159 patients. J Thorac Cardiovasc Surg . 1996; 112 867-874
39 Labow D M, Buell J E, Yoshida A, Rosen S, Posner M C. Isolated pulmonary recurrence after resection of colorectal hepatic metastases-is resection indicated?. Cancer J . 2002; 8 342-347
40 Hamy A, Baron O, Bennouna J. et al . Rsection of hepatic and pulmonary metastases in patients with colorectal cancer. Am J Clin Oncol . 2001; 24 607-609
41 Gauden S, Tripcony L. The curative treatment by radiation therapy alone of stage I non-small cell lung cancer in a geriatric population. Lung Cancer . 2001; 32 71-79
42 Dekernion J B, Ramming K P, Smith R B. The natural history of metastatic renal cell carcinoma: a computer analysis. J Urol . 1978; 120 148-152
43 Glenn D W, Clark W, Morris D L. et al .Percutaneous radiofrequency ablation of colorectal pulmonary metastases. In: RSNA Conference 2001; November 25-30; Chicago, IL
44 de Baere T, Elias D, Dromain C. et al . Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. AJR . 2001; 175 1619-1625
45 Hoegler D. Radiotherapy for palliation symptoms in incurable cancer. Curr Probl Cancer . 1997; 21 129-183
46 Todd T R. The surgical treatment of pulmonary metastases. Chest . 1997; 112 287S-290S
47 Pastorino U, Buyse M, Friedel G. et al . Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. The International Registry of Lung Metastases. J Thorac Cardiovasc Surg . 1997; 113 37-49
48 Sakamoto T, Tsubota N, Ivanaga K. et al . Pulmonary resection for metastases from colorectal cancer. Chest . 2001; 119 1069-1072
49 Fourquier P, Regnard J, Rea S. et al . Lung metastases of renal cell carcinoma: results of surgical resection. Eur J Cardiothorac Surg . 1997; 11 17-21
50 Kandioler D, Kromer E, Tuchler H. et al . Long-term results after repeated surgical removal of pulmonary metastases. Ann Thorac Surg . 1998; 65 909-912
51 Kang S, Luo R, Liao W. et al .Evaluation of PET in radiofrequency ablation of lung tumors. Paper presented at: The American Society of Clinical Oncology, held in Chicago, IL, May 30-June 3 Abstract (No 2738) 2003
52 Steinke K, Habicht J M. ThomsenS, Soler M, Jacob AL. CT-guided radiofrequecny ablation of a pulmonary metastasis followed by surgical resection. Cardiovasc Intervent Radiol . 2002; 25 543-546
53 Miao Y, Yicheng N, Bosmans H. et al . Radiofrequency ablation for eradication of pulmonary tumor in rabbits. J Surg Res . 2001; 99 265-271
54 Downey R J, Martini N, Rusch V. et al . Extent of chest wall invasion and survival in patients with lung cancer. Ann Thorac Surg . 1999; 68 188-193
55 Elia S, Griffo S, Gentile M. et al . Surgical treatment of lung cancer invading chest wall: a retrospective analysis of 110 patients. Eur J Cardiothorac Surg . 2001; 20 356-360
56 Landreneau R J, Sugarbaker D J, Mack M J. et al . Wedge resection versus lobectomy for stage 1(T1 N0 M0) non-small cell lung cancer. J Thorac Cardiovasc Surg . 1997; 113 691-698
57 Martini N, Bains M S, Burt M E. et al . Incidence of local recurrence and second primaries in resected stage I lung cancer. J Thorac Cardiovasc Surg . 1995; 109 120-129
58 Mountain C F. A new international staging system for lung cancer. Chest . 1986; 89(4 suppl) 225-233
59 Naruke T, Goya T, Tsuchiya R. et al . Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg . 1988; 96 440-447
60 Shimizu J, Watanabe Y, Oda M. et al . Results of surgical treatment of stage I lung cancer. Nippon Geka Gakkai Zasshi . 1993; 94 505-510
61 Williams D E, Pairolero P C, Danis C S. et al . Survival of patients surgically treated for stage I lung cancer. J Thorac Cardiovasc Surg . 1981; 82 70-76
62 Herrera L J, Fernando H C, Perry Y. et al . Radiofrequency ablation of pulmonary malignant tumors in nonsurgical candidates. J Thorac Cardiovasc Surg . 2003; 125 929-937
63 Lencioni R A, Crocetti L, Cioni R. et al .Percutaneous radiofrequency thermal ablation of non-small-cell lung cancer. Paper presented at: The American Society of Clinical Oncology held in Chicago, IL, May 30-June 3 Abstract (No 2655). 2003
64 Dupuy D, Chauhan B, Ready N. et al .Radiofrequency ablation (RFA) followed by conventional radiotherapy (RT) for inoperable non-small cell lung cancer (NSCLC). Paper presented at: The American Society of Clinical Oncology, held in Chicago, IL, May 30-June 3 Abstract (No 2632). 2003
65 Martini N. Surgical treatment of non-small cell lung cancer by stage. Semin Surg Oncol . 1990; 6 248-254
66 Kodama K, Doi O, Higashiymama M. et al . Intentional limited resection for selected patients with T1 N0 non-small cell lung cancer: a single-institution study. J Thorac Cardiovasc Surg . 1997; 114 347-353
67 Okada M, Yoshikawa K, Hatta T. et al . Is segmentectomy with lymph node assessment an alternative to lobectomy for non-small cell lung cancer of 2 cm or smaller?. Ann Thorac Surg . 2001; 71 956-960
68 Okamoto Y, Murakami M, Yoden E. et al . Reirradiation for locally recurrent lung cancer previously treated with radiation therapy. Int J Radiat Oncol Biol Phys . 2002; 52 390-396
69 Ramsey S D, Peacock S, Goodman G. et al .Prevalence of older patients with advanced non-small cell lung cancer receiving no treatment: evidence from the SEER-Medicare database. Paper presented at: The American Society of Clinical Oncology, held in Chicago, IL, May 30-June 3 Abstract (No 2586). 2003